Atossa Therapeutics (ATOS) Non-Current Assets (2011 - 2026)
Atossa Therapeutics' Non-Current Assets was $1.27 million in Q2 2026, down 36.4% from $2 million a year earlier and down 0.3% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Atossa Therapeutics came in at $1.99 million, up 0.2% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 95.9% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $1.99 million in FY2024 (-50.7%), $4.03 million in FY2023 (-24.4%), $5.34 million in FY2022 and $22,000 in FY2021 (-68.1%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q2 2022.
- Compared with a year earlier, Non-Current Assets was higher in 1 of the last eight quarters, with an average decline of 33.5%.
- The best year-over-year quarter for Non-Current Assets over five years was Q1 2023 (growth of 746.2%); the worst was Q3 2021 (a decline of 69.2%).
- Per Business Quant data, ATOS's Non-Current Assets in the three quarters before Q2 2026 was $1.28 million (Q1 2026), $1.99 million (Q4 2025) and $2.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | 1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 4.14 Mn |
| Mar 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | 4.05 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 5.34 Mn |
| Sep 30, 2022 | 3.33 Mn |
| Jun 30, 2022 | 627,000.00 |
| Mar 31, 2022 | 630,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 36,763.00 |
API Access
Atossa Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();